Over 100 million women screened for HPV with QIAGEN solutions. We are proud to be a partner in fighting cervical cancer with our HPV testing solutions. Learn about our commitment to screening 100 million more. We are committed to reaching every woman with our comprehensive portfolio, which includes tests for diverse menu options, risk stratification, and limited resource settings.
QIAscreen is an in vitro real-time PCR-based assay for the qualitative detection of human papillomavirus (HPV) DNA of 15 (likely) (1) high-risk HPV genotypes. QIAscreen combines QIAGEN’s leading sample prep excellence from QIAsymphony and Rotor Gene with our expertise in HPV diagnostics.
Watch the video to learn more about the new QIAscreen test.
Not all HPV-positives are the same. Be confident in the difference with QIAsure.
With QIAsure, clinicians can stratify the risk of high risk-HPV positive patients. This innovative test objectively detects the presence of biomarkers associated with cervical precancer and cancer in the PCR lab, using the same sample from an HPV or liquid-based cytology test. QIAsure provides peace of mind for patients to live their lives with confidence about their reproductive health.
Adaptable and affordable high-risk HPV test
With proper training, the careHPV Test is run by healthcare workers with no formal laboratory skills.
The careHPV Test runs on electricity or a battery with an inverter, making it portable and adaptable.
The temperature range is flexible, from 15°C to 40°C.
Additional careHPV Test benefits include:
The careHPV test is on the WHO’s list of prequalified in vitro diagnostics, meaning it is suitable for cervical cancer screening in resource-limited settings and eligible for inclusion in UN procurement tenders. This status significantly broadens access to HPV DNA testing to areas of the world with a high burden of cervical cancer.
When it comes to cervical cancer screening, sensitivity is the key. Early detection allows you to make more thorough and informed patient management decisions. The digene HC2 HPV Test is:
Additionally, the digene HC2 HPV Test:
See how the digene HC2 HPV test is the gold standard in Ivana Hojsikova’s work.
Jose Eduardo Levi uses digene HC2 and believes HPV testing should be available for all women worldwide.
In Russia, digene HC2’s high sensitivity is why this is their test of choice.
Murat Gueltekin describes the impact of the digene HC2 test on Turkey’s cervical cancer screening program.
1. International Agency for Research on Cancer. (2009). A review of human carcinogens. Part B: Biological Agents. Monographs 100B.